Health
Oxford/AstraZeneca vaccine: rare blood clot syndrome has high mortality rate – The Guardian
Researchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people
CoronavirusResearchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people
Although extremely rare, a blood clot syndrome after the first dose of the Oxford/AstraZeneca vaccine carries a high risk of death…
Continue Reading
-
Business5 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Business9 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
Noosa News23 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment